Should I buy or sell OmniAb stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OmniAb in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OABI shares. View OABI analyst ratings or view top-rated stocks .

What is OmniAb's stock price target for 2024?

4 equities research analysts have issued 12-month price objectives for OmniAb's shares. Their OABI share price targets range from $7.00 to $11.00. On average, they predict the company's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 92.7% from the stock's current price. View analysts price targets for OABI or view top-rated stocks among Wall Street analysts .

How have OABI shares performed in 2024?

OmniAb's stock was trading at $6.17 on January 1st, 2024. Since then, OABI shares have decreased by 24.3% and is now trading at $4.67. View the best growth stocks for 2024 here .

When is OmniAb's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our OABI earnings forecast .

How were OmniAb's earnings last quarter?

OmniAb, Inc. (NASDAQ:OABI) released its quarterly earnings data on Wednesday, March, 20th. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.03. The business earned $4.82 million during the quarter, compared to analyst estimates of $6.94 million. OmniAb had a negative net margin of 148.16% and a negative trailing twelve-month return on equity of 15.41%.

Who are OmniAb's major shareholders?

OmniAb's stock is owned by many different retail and institutional investors. Top institutional shareholders include Woodstock Corp (0.64%), Allspring Global Investments Holdings LLC (0.07%), Mesirow Financial Investment Management Inc. (0.03%) and Trivant Custom Portfolio Group LLC (0.01%). Insiders that own company stock include Jennifer R Cochran, John L Higgins, Kurt A Gustafson and Matthew W Foehr. View institutional ownership trends .

How do I buy shares of OmniAb?

Shares of OABI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:OABI

OmniAb (OABI) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free OABI Stock Alerts

$4.67

+0.08 (+1.74%)

(As of 04/19/2024 ET)

Compare

Today's Range: $4.52
▼
$4.67
50-Day Range: $4.59
▼
$6.33
52-Week Range: $3.14
▼
$6.72

Volume: 930,364 shs
Average Volume: 470,418 shs
Market Capitalization: $547.00 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $9.00

Get OmniAb alerts:

OmniAb MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 92.7% Upside
$9.00 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$1.17 M Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.58) to ($0.34) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.74 out of 5 stars

Medical Sector

622nd out of 911 stocks

Commercial Physical Research Industry

10th out of 12 stocks

3.5

Analyst's Opinion

Consensus Rating
OmniAb has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
OmniAb has only been the subject of 4 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for OABI.

0.0

Dividend Strength

Dividend Yield
OmniAb does not currently pay a dividend.
Dividend Growth
OmniAb does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OABI.

0.6

News and Social Media Coverage

Search Interest
3 people have searched for OABI on MarketBeat in the last 30 days.
MarketBeat Follows
Only 5 people have added OmniAb to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, OmniAb insiders have bought 1,052.27% more of their company's stock than they have sold. Specifically, they have bought $1,167,750.00 in company stock and sold $101,343.00 in company stock.
Percentage Held by Insiders
Only 7.00% of the stock of OmniAb is held by insiders.
Percentage Held by Institutions
72.08% of the stock of OmniAb is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for OmniAb are expected to grow in the coming year, from ($0.58) to ($0.34) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of OmniAb is -9.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of OmniAb is -9.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
OmniAb has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About OmniAb Stock (NASDAQ:OABI)

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

OABI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OABI Stock News Headlines

April 10, 2024 | insidertrades.com

Insider Selling: OmniAb, Inc. (NASDAQ:OABI) CFO Sells 6,954 Shares of Stock

April 3, 2024 | insidertrades.com

Kurt A. Gustafson Sells 11,849 Shares of OmniAb, Inc. (NASDAQ:OABI) Stock

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 26, 2024 | insidertrades.com

Matthew W. Foehr Acquires 225,000 Shares of OmniAb, Inc. (NASDAQ:OABI) Stock

April 11, 2024 | investing.com

OmniAb's chief legal officer sells shares worth over $36k

April 10, 2024 | americanbankingnews.com

OmniAb, Inc. (NASDAQ:OABI) CFO Kurt A. Gustafson Sells 6,954 Shares of Stock

April 9, 2024 | markets.businessinsider.com

RBC Capital Remains a Buy on OmniAb (OABI)

March 28, 2024 | msn.com

Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 26, 2024 | finance.yahoo.com

OmniAb, Inc. (NASDAQ:OABI) Analysts Are More Bearish Than They Used To Be

March 25, 2024 | finance.yahoo.com

OmniAb Inc (OABI) President and CEO Matthew Foehr Acquires 225,000 Shares

March 22, 2024 | markets.businessinsider.com

Benchmark Co. Reaffirms Their Buy Rating on OmniAb (OABI)

March 21, 2024 | markets.businessinsider.com

OmniAb’s Market Potential and Financial Stability Affirm Buy Rating

March 21, 2024 | finance.yahoo.com

OmniAb, Inc. (NASDAQ:OABI) Q4 2023 Earnings Call Transcript

March 21, 2024 | markets.businessinsider.com

OmniAb’s Strategic Growth and Resilience Reinforce Buy Rating Amidst Q4 Revenue Shortfall

March 20, 2024 | msn.com

OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023

March 20, 2024 | finance.yahoo.com

OmniAb Inc (OABI) Reports Decline in Annual Revenue and Net Loss for Q4 and Full Year 2023

March 20, 2024 | seekingalpha.com

OmniAb, Inc. 2023 Q4 - Results - Earnings Call Presentation

March 20, 2024 | benzinga.com

Recap: OmniAb Q4 Earnings

March 20, 2024 | finance.yahoo.com

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

February 28, 2024 | realmoney.thestreet.com

2 Speculative Small-Cap Biotech Stocks You Should Know About

February 26, 2024 | businesswire.com

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

February 26, 2024 | businesswire.com

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20

February 20, 2024 | finance.yahoo.com

OmniAb to Participate in Two Investor Conferences in March

February 20, 2024 | businesswire.com

OmniAb to Participate in Two Investor Conferences in March

February 2, 2024 | morningstar.com

OmniAb Inc OABI

January 27, 2024 | markets.businessinsider.com

OmniAb (OABI) Receives a Buy from RBC Capital

See More Headlines

Receive OABI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OmniAb and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/20/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Commercial physical research
Sub-Industry: N/A
Current Symbol: NASDAQ:OABI
CUSIP: N/A
CIK: 1846253
Web: www.omniab.com
Phone: 510-250-7800
Fax: N/A
Employees: 106
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $9.00
High Stock Price Target: $11.00
Low Stock Price Target: $7.00
Potential Upside/Downside: +92.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.51)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-50,620,000.00
Net Margins: -148.16%
Pretax Margin: -188.39%
Return on Equity: -15.41%
Return on Assets: -12.77%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.11
Quick Ratio: 4.11

Sales & Book Value

Annual Sales: $34.16 million
Price / Sales: 16.01
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.69 per share
Price / Book: 1.74

Miscellaneous

Outstanding Shares: 117,130,000
Free Float: 108,927,000
Market Cap: $547.00 million
Optionable: Optionable
Beta: -0.18

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Matthew W. Foehr (Age 51)
President, CEO & Director
Comp: $967.72k
Mr. Kurt A. Gustafson (Age 56)
Executive VP of Finance & CFO
Comp: $558.48k
Mr. Charles S. Berkman J.D. (Age 55)
Chief Legal Officer & Secretary
Comp: $734.33k
Ms. Cia McCaffrey
Vice President of People & Talent
Dr. Bill Harriman Ph.D.
Senior Vice President of Antibody Discovery
Ms. Marie-Cecile van de Lavoir D.V.M.
Ph.D., Senior Vice President of Technical Operations & Genetics
Dr. Christel Iffland Ph.D.
Senior Vice President of Antibody Technologies
Dr. Douglas S. Krafte Ph.D. (Age 66)
Senior VP of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head
Ms. Donna Ventura CPA
Senior Vice President of Corporate Controller

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OABI Stock Analysis - Frequently Asked Questions

Should I buy or sell OmniAb stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OmniAb in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OABI shares.
View OABI analyst ratings or view top-rated stocks.
What is OmniAb's stock price target for 2024?: 4 equities research analysts have issued 12-month price objectives for OmniAb's shares. Their OABI share price targets range from $7.00 to $11.00. On average, they predict the company's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 92.7% from the stock's current price.
View analysts price targets for OABI or view top-rated stocks among Wall Street analysts.
How have OABI shares performed in 2024?: OmniAb's stock was trading at $6.17 on January 1st, 2024. Since then, OABI shares have decreased by 24.3% and is now trading at $4.67.
View the best growth stocks for 2024 here.
When is OmniAb's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our OABI earnings forecast.

How were OmniAb's earnings last quarter?: OmniAb, Inc. (NASDAQ:OABI) released its quarterly earnings data on Wednesday, March, 20th. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.17) by $0.03. The business earned $4.82 million during the quarter, compared to analyst estimates of $6.94 million. OmniAb had a negative net margin of 148.16% and a negative trailing twelve-month return on equity of 15.41%.
Who are OmniAb's major shareholders?: OmniAb's stock is owned by many different retail and institutional investors. Top institutional shareholders include Woodstock Corp (0.64%), Allspring Global Investments Holdings LLC (0.07%), Mesirow Financial Investment Management Inc. (0.03%) and Trivant Custom Portfolio Group LLC (0.01%). Insiders that own company stock include Jennifer R Cochran, John L Higgins, Kurt A Gustafson and Matthew W Foehr.
View institutional ownership trends.
How do I buy shares of OmniAb?: Shares of OABI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OABI) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

OmniAb (OABI) Stock Price, News & Analysis

OmniAb MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About OmniAb Stock (NASDAQ:OABI)

OABI Stock Price History

OABI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

OABI Stock Analysis - Frequently Asked Questions

Overall MarketRank^™